Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improvement of pressure flow parameters with finasteride is greater in men with large prostates. Finasteride Urodynamics Study Group.
Abrams P, Schäfer W, Tammela TL, Barrett DM, Hedlund H, Rollema HJ, Matos-Ferreira A, Nordling J, Bruskewitz R, Andersen JT, Hald T, Miller P, Kirby R, Mustonen S, Cannon A, Jacobsen CA, Gormley GJ, Malice MP, Bach MA. Abrams P, et al. Among authors: bruskewitz r. J Urol. 1999 May;161(5):1513-7. J Urol. 1999. PMID: 10210385 Clinical Trial.
Repeated pressure-flow studies in the evaluation of bladder outlet obstruction due to benign prostatic enlargement. Finasteride Urodynamics Study Group.
Tammela TL, Schäfer W, Barrett DM, Abrams P, Hedlund H, Rollema HJ, Matos-Ferreira A, Nordling J, Bruskewitz R, Miller P, Kirby R, Andersen JT, Jacobsen C, Gormley GJ, Malice MP, Bach MA. Tammela TL, et al. Among authors: bruskewitz r. Neurourol Urodyn. 1999;18(1):17-24. doi: 10.1002/(sici)1520-6777(1999)18:1<17::aid-nau4>3.0.co;2-m. Neurourol Urodyn. 1999. PMID: 10090123 Clinical Trial.
Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years. Finasteride Urodynamics Study Group.
Schäfer W, Tammela TL, Barrett DM, Abrams P, Hedlund H, Rollema HJ, Nordling J, Andersen JT, Hald T, Matos-Ferriera A, Bruskewitz R, Miller P, Mustonen S, Cannon A, Malice MP, Jacobsen CA, Bach MA. Schäfer W, et al. Among authors: bruskewitz r. Urology. 1999 Aug;54(2):278-83. doi: 10.1016/s0090-4295(99)00130-2. Urology. 1999. PMID: 10443725 Clinical Trial.
Effect of finasteride on bother and other health-related quality of life aspects associated with benign prostatic hyperplasia. PLESS Study Group. Proscar Long-term Efficacy and Safety Study.
Bruskewitz R, Girman CJ, Fowler J, Rigby OF, Sullivan M, Bracken RB, Fusilier HA, Kozlowski D, Kantor SD, Johnson EL, Wang DZ, Waldstreicher J. Bruskewitz R, et al. Urology. 1999 Oct;54(4):670-8. doi: 10.1016/s0090-4295(99)00209-5. Urology. 1999. PMID: 10510926 Clinical Trial.
Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia.
Kaplan SA, Holtgrewe HL, Bruskewitz R, Saltzman B, Mobley D, Narayan P, Lund RH, Weiner S, Wells G, Cook TJ, Meehan A, Waldstreicher J; Proscar Long-Term Efficacy and Safety Study Group. Kaplan SA, et al. Among authors: bruskewitz r. Urology. 2001 Jun;57(6):1073-7. doi: 10.1016/s0090-4295(01)00985-2. Urology. 2001. PMID: 11377309 Clinical Trial.
Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group.
Roehrborn CG, Bruskewitz R, Nickel GC, Glickman S, Cox C, Anderson R, Kandzari S, Herlihy R, Kornitzer G, Brown BT, Holtgrewe HL, Taylor A, Wang D, Waldstreicher J. Roehrborn CG, et al. Among authors: bruskewitz r. Eur Urol. 2000 May;37(5):528-36. doi: 10.1159/000020189. Eur Urol. 2000. PMID: 10765090 Clinical Trial.
154 results